BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7385461)

  • 1. Improvement of lung function in a scleroderma patient treated for 12 months with cyclofenil.
    Blom-Bülow B; Fridriksson H; Herbai G
    Ups J Med Sci; 1980; 85(1):67-73. PubMed ID: 7385461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of progressive systemic sclerosis with a synthetic weak estrogen: cyclofenil (Sexovid). Report of a case.
    Herbai G
    Acta Med Scand; 1974 Dec; 196(6):537-40. PubMed ID: 4456988
    [No Abstract]   [Full Text] [Related]  

  • 3. Cyclofenil treatment of scleroderma--a controlled study.
    Gibson T; Grahame R
    Br J Rheumatol; 1983 Nov; 22(4):218-23. PubMed ID: 6360282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of acrosclerosis with cyclofenil].
    Altomare GF; Zanotti M
    Clin Ter; 1982 Mar; 100(6):597-603. PubMed ID: 7083788
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of progressive systemic sclerosis (PSS) with cyclofenil.
    Corrocher R; Morittu L; Bambara LM; De Sandre G
    Clin Exp Rheumatol; 1983; 1(4):359-60. PubMed ID: 6681154
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyclofenil versus placebo in progressive systemic sclerosis. A one-year double-blind crossover study of 27 patients.
    Blom-Bülow B; Oberg K; Wollheim FA; Persson B; Jonson B; Malmberg P; Boström H; Herbai G
    Acta Med Scand; 1981; 210(5):419-28. PubMed ID: 7039242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of cyclofenil treatment on arterial insufficiency demonstrated in a patient by colour thermography.
    Herbai G; Boczán J
    Acta Med Scand; 1980; 207(1-2):127-30. PubMed ID: 7368965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclofenil in the treatment of scleroderma - a general view on the results after treating 29 cases.
    Bülow BB; Boström H; Herbai G; Persson B; Wollheim F; Oberg K
    Z Rheumatol; 1980; 39(1-2):1-8. PubMed ID: 7424193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Scleroderma and esophageal changes: treatment and instrumental control].
    Altomare GF; Allara A; Pigatto PD
    G Ital Dermatol Venereol; 1984; 119(4):263-6. PubMed ID: 6490099
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of progressive systemic sclerosis (scleroderma, PSS) with a new drug influencing connective tissue.
    Herbai G; Blom B; Boström H
    Acta Med Scand; 1977; 201(3):203-6. PubMed ID: 848357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclofenil in childhood scleroderma.
    Høgh B; Stenhammar L
    Acta Derm Venereol; 1983; 63(5):445-6. PubMed ID: 6197849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term evaluation of penicillamine or cyclofenil in systemic sclerosis. Results from a two-year randomized study.
    Akesson A; Blom-Bülow B; Scheja A; Wollmer P; Valind S; Wollheim FA
    Scand J Rheumatol; 1992; 21(5):238-44. PubMed ID: 1439632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic reactions to cyclofenil.
    Olsson R; Tyllström J; Zettergren L
    Gut; 1983 Mar; 24(3):260-3. PubMed ID: 6826112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal changes in lung function and respiratory symptoms in progressive systemic sclerosis. Prospective study.
    Greenwald GI; Tashkin DP; Gong H; Simmons M; Duann S; Furst DE; Clements P
    Am J Med; 1987 Jul; 83(1):83-92. PubMed ID: 3300327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclofenil-induced hemolytic anemia in scleroderma.
    Russell ML; Schachter RK
    Acta Med Scand; 1981; 210(5):431-2. PubMed ID: 7336999
    [No Abstract]   [Full Text] [Related]  

  • 16. Usefulness of cyclophenyl in the treatment of morphea.
    Pachor ML; Nicolis F; Lunardi C; Bambara LM; Marchi G; Urbani G; Corrocher R; De Sandre G
    Riv Eur Sci Med Farmacol; 1987 Sep; 9(3):257-60. PubMed ID: 3508600
    [No Abstract]   [Full Text] [Related]  

  • 17. Morphea: treatment of two clinical cases with cyclophenyl.
    Pachor ML; Nicolis F; Lunardi C; Bambara LM; Marchi G; Urbani G; Corrocher R; De Sandre G
    Clin Exp Rheumatol; 1987; 5(3):293-4. PubMed ID: 3427845
    [No Abstract]   [Full Text] [Related]  

  • 18. Hemolytic anemia during cyclofenil treatment of scleroderma.
    Wollheim FA; Ljunggren HO; Blom-Bülow B
    Acta Med Scand; 1981; 210(5):429-30. PubMed ID: 7039243
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation by integrated thermography of the beneficial effect of cyclofenil in severe subcutaneous arterial insufficiency.
    Herbai G; Boczan J; Marsden NV; Ljunghall S
    Ups J Med Sci; 1985; 90(1):61-6. PubMed ID: 4002441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of lung function in patients with systemic sclerosis after 6 months cyclophosphamide pulse therapy.
    Ostojic P; Damjanov N
    Clin Rheumatol; 2006 Nov; 25(6):819-21. PubMed ID: 16440134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.